MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy

References

• KoppenIHermansFKaspersGFolate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemiaBr J Haematol200914831419775302
   PubMed Web of Science ®Google Scholar
• JohnstonWTLightfootTJSimpsonJRomanEChildhood cancer survival : a report from the United Kingdom Childhood Cancer StudyCancer Epidemiol201034665966620674536
   PubMed Web of Science ®Google Scholar
• PuiCRobisonLLookAAcute lymphoblastic leukaemiaLancet20083711030104318358930
   PubMed Web of Science ®Google Scholar
• GorlickRGokerETrippettRWalthamMBanerjeeDBertinoJIntrinsic and acquired resistance to methotrexate in acute leukemiaN Engl J Med1996335104110488793930
   PubMed Web of Science ®Google Scholar
• KrajinovicMMoghrabiAPharmacogenetics of methotrexatePharmacogenomics20045781983415469405
   PubMed Web of Science ®Google Scholar
• De MattiaEToffoliGC677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisationEur J Cancer20094581333135119144510
   PubMed Web of Science ®Google Scholar
• CheokMEvansWAcute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapyNat Rev Cancer20066211713016491071
   PubMed Web of Science ®Google Scholar
• FrosstPBlomHMilosRA candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNat Genet19951011111137647779
   PubMed Web of Science ®Google Scholar
• WeisbergIJacquesPSelhubJThe 1298A/C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteineAtherosclerosis2001156240941511395038
   PubMed Web of Science ®Google Scholar
• NiedzielskaEWęcławek-TompolJMatkowska-KocjanAChybickaAThe influence of genetic RFC1, MS and MTHFR polymorphisms on the risk of acute lymphoblastic leukemia relapse in children and the adverse effects of methotrexateAdv Clin Exp Med2013224579584 Available from: http://www.ncbi.nlm.nih.gov/pubmed/2398621923986219
   PubMed Web of Science ®Google Scholar
• Lopez-LopezEMartin-GuerreroIBallesterosJPolymorphisms of the SLCO1B1 gene predict methotrexate-related toxicity in childhood acute lymphoblastic leukemiaPediatr Blood Cancer201157461261921387541
   PubMed Web of Science ®Google Scholar
• Lopez-LopezEGutierrez-CaminoABilbao-AldaiturriagaNPombar-GomezMMartin-GuerreroIGarcia-OradAPharmacogenetics of childhood acute lymphoblastic leukemiaPharmacogenomics201415101383139825155938
   PubMed Web of Science ®Google Scholar
• EstellerMAberrant DNA methylation as a cancer-inducing mechanismAnnu Rev Pharmacol Toxicol20054562965615822191
   PubMed Web of Science ®Google Scholar
• AbeMOhiraMKanedaACpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomasCancer Res200565382883415705880
   PubMed Web of Science ®Google Scholar
• Lopez-LopezEMartin-GuerreroIBallesterosJGarcia-OradAA systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemiaPharmacogenomics J201313649850623089671
   PubMed Web of Science ®Google Scholar
• YangLHuXXuLImpact of methylenetetrahydrofolate reductase (MTHFR) polymorphisms on methotrexate-induced toxicities in acute lymphoblastic leukemia: a meta-analysisTumor Biol201267714451454
   Google Scholar
• YanagimachiMGotoHKanekoTInfluence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapyInt J Hematol201398670270724241962
   PubMed Web of Science ®Google Scholar
• TorunYAPatirogluTOzdemirMAOzkulYEkiciAKarakukcuMInherited prothrombotic risk factors in Turkish children with acute lymphoblastic leukemia: significance of concomitant genetic mutationClin Appl Thromb Hemost201218221822121873357
   PubMed Web of Science ®Google Scholar
• SivasliogluSGurselTKocakUKayaZThe risk factors for thrombosis in children with acute lymphoblastic leukemiaClin Appl Thromb Hemost201420665165323364161
   PubMed Web of Science ®Google Scholar
• AbdelazizDHElhosseinyNMKhaleelSASabryNAAttiaASEl-SayedMHAssociation between combined presence of Hepatitis C Virus and polymorphisms in different genes with toxicities of methotrexate and 6-mercaptopurine in children with acute lymphoblastic leukemiaPediatr Blood Cancer20166391539154527163515
   PubMed Web of Science ®Google Scholar
• TanakaYManabeANakadateHMethylenetetrahydrofolate reductase gene haplotypes affect toxicity during maintenance therapy for childhood acute lymphoblastic leukemia in Japanese patientsLeuk Lymphoma20145551126113123865834
   PubMed Web of Science ®Google Scholar
• KaluznaEStraussEZajac-SpychalaOFunctional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemiaEur J Pharmacol2015769939926528799
   PubMed Web of Science ®Google Scholar
• Karas KuzelickiNMilekMJazbecJMlinaric-RascanI5,10-Methylenetetrahydrofolate reductase (MTHFR) low activity genotypes reduce the risk of relapse-related acute lymphoblastic leukemia (ALL)Leuk Res200933101344134819178944
   PubMed Web of Science ®Google Scholar
• Ramírez-PachecoAMoreno-GuerreroSAlamilloIMedina-SansonALopezBMoreno-GalvanMMexican childhood acute lymphoblastic leukemia: a pilot study of the MDR1 and MTHFR gene polymorphisms and their associationsGenet Test Mol biomrkers20162010597602
   PubMed Web of Science ®Google Scholar
• HaaseRElsnerKStiefelMMauz-KorholzCKrammCKorholzDHigh dose methotrexate treatment in childhood ALL : pilot study on the impact of the MTHFR 677C > T and 1298A > C polymorphisms on MTX-related toxicityKlin Pädiatrie20122243156159
   PubMed Web of Science ®Google Scholar
• AráozHAloiKFoncubertaMPharmacogenetic studies in children with acute lymphoblastic leukemia in Argentina Pharmacogenetic studies in children with acute lymphoblastic leukemia in ArgentinaLeuk Lymphoma20155651370137825110820
   PubMed Web of Science ®Google Scholar
• ZgheibNAkra-IsmailMAridiCGenetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemiaPharmacogenet Genomics201424838739625007187
   PubMed Web of Science ®Google Scholar
• FukushimaHFukushimaTSakaiAPolymorphisms of MTHFR associated with higher relapse/death ratio and delayed weekly MTX administration in pediatric lymphoid malignanciesLeuk Res Treatment2013201319
   Google Scholar
• ImanishiHOkamuraNYagiMGenetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphomaJ Hum Genet200752216617117180579
   PubMed Web of Science ®Google Scholar
• SuzukiRFukushimaHNoguchiEInfluence of SLCO1B1 polymorphism on maintenance therapy for childhood leukemiaPediatr Int201557457257725939871
   PubMed Web of Science ®Google Scholar
• MoulikNKumarAAgrawalSMahdiAKumarAEffect of folate status and methylenetetrahydrofolate reductase genotypes on the complications and outcome of high dose methotrexate chemotherapy in north Indian children with acute lymphoblastic leukemiaIndian J Med Paediatr Oncol2016372858927168705
   PubMedGoogle Scholar
• YazicioğluBKayaZErgunSInfluence of folate-related gene polymorphisms on high-dose methotrexate-related toxicity and prognosis in Turkish children with Acute Lymphoblastic LeukemiaTurkish J Hematol2016219
   Web of Science ®Google Scholar
• KantarMKosovaBCetingulNMethylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphomaLeuk Lymphoma200950691291719391036
   PubMed Web of Science ®Google Scholar
• KarathanasisNVStiakakiEGoulielmosGNKalmantiMThe role of the methylenetetrahydrofolate reductase 677 and 1298 polymorphisms in Cretan children with acute lymphoblastic leukemiaGenet Test Mol Biomarkers2011151–251021117954
   PubMed Web of Science ®Google Scholar
• HeHChenSYouHAssociation between methylenetetrahydrofolate reductase polymorphisms and the relapse of acute lymphoblastic leukemia: a meta-analysisPharmacogenomics J201414543243824637499
   PubMed Web of Science ®Google Scholar
• OjhaRPGurneyJGMethylenetetrahydrofolate reductase C677T and overall survival in pediatric acute lymphoblastic leukemia: a systematic reviewLeuk Lymphoma2014551677323550988
   PubMed Web of Science ®Google Scholar
• D´AngeloVRamagliaMIannottaAMethotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinantsCancer Chemother Pharmacol20116851339134621590445
   PubMed Web of Science ®Google Scholar
• TantawyAEl-BostanyEAdlyAMethylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemiaBlood Coagul Fibrinolysis2010211283419923983
   PubMed Web of Science ®Google Scholar
• RadtkeSZolkORennerBGermline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemiaBlood J20131212651455154
   PubMed Web of Science ®Google Scholar
• TreviñoLShimasakiNYangWGermline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effectsJ Clin Oncol200927355972597819901119
   PubMed Web of Science ®Google Scholar
• RamseyLBPanettaJCSmithCGenome-wide study of methotrexate clearance replicates SLCO1B1Blood2013121689890423233662
   PubMed Web of Science ®Google Scholar
• Lopez-LopezEBallesterosJPinanMAPolymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemiaPharmacogenet Genomics2013232536123222202
   PubMedGoogle Scholar
• den HoedMALopez-LopezEte WinkelMLGenetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemiaPharmacogenomics J201515324825425348617
   PubMed Web of Science ®Google Scholar
• Gutierrez-CaminoALopez-LopezEGarcia-OradASLC19A1 hot spot for MTX plasma concentrationMed Oncol2014311020425178938
   PubMed Web of Science ®Google Scholar
• IparraguirreLGutierrez-CaminoAUmerezMMiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemiaPharmacogenet Genomics2016261151752527649261
   PubMed Web of Science ®Google Scholar
• Lopez-LopezEGutierrez-CaminoAPinanMAPharmacogenetics of microRNAs and microRNAs biogenesis machinery in pediatric acute lymphoblastic leukemiaPLoS One201493e9126124614921
   PubMed Web of Science ®Google Scholar
• TsujimotoSTanakaFYanagimachiMInfluence of ADORA2A gene polymorphism on leukoencephalopathy risk in MTX-treated pediatric patients affected by hematological malignanciesPediatr Blood Cancer2016631983198927399166
   PubMed Web of Science ®Google Scholar
• WangSSunLZengWWuWZhangGInfluence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemiaCancer Chemother Pharmacol20147428328924908438
   PubMed Web of Science ®Google Scholar
• de DeusDde LimaESeabra SilvaRLeiteECartaxo MunizMInfluence of methylenetetrahydrofolate reductase C677T, A1298C, and G80A polymorphisms on the survival of pediatric patients with acute lymphoblastic leukemiaLeuk Res Treatment2012201216
   Google Scholar
• KimHKangHKimHPharmacogenetic analysis of pediatric patients with acute lymphoblastic leukemia: a possible association between survival rate and ITPA polymorphismPLoS One201279110
   Web of Science ®Google Scholar
• LeonardiDAbbateMRiccheriMImproving risk stratification of patients with childhood acute lymphoblastic leukemia: glutathione-S-transferases polymorphisms are associated with increased risk of relapseOncotarget2016518
   Google Scholar
• HoangPAmbroiseJDekairelleAComparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?Br J Clin Pharmacol201579342944025099492
   PubMed Web of Science ®Google Scholar